The Zika outbreak in Miami's Wynwood arts district centered on three businesses with outdoor areas shared by employees, customers and breeding mosquitoes, and the number of people infected was likely greater than reported, ...
Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.
Finally, science comes to the rescue of those of us who have been told all our lives to "sit still."
(HealthDay)—Bundling of the Current Procedural Terminology (CPT) codes for facet injections with image guidance and limiting billing to a maximum of three levels, implemented in 2010, correlated with a large decrease in ...
(HealthDay)—A social support intervention can improve social support and quality of life (QOL) for individuals living with HIV/AIDS, according to a study published online Sept. 20 in the Journal of Clinical Nursing.
(HealthDay)—In germ cell tumors (GCTs), TP53 and MDM2 alterations correlate with cisplatin resistance and are associated with inferior outcome, according to a study published online Sept. 19 in the Journal of Clinical Oncology.
Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies.
(HealthDay)—Urokinase plasminogen activator receptor (uPAR) is elevated in patients with asthma, with high uPAR levels linked to severe, non-atopic disease, according to a study published online Sept. 14 in Allergy.
(HealthDay)—Pregabalin is beneficial for neuropathic pain, regardless of previous gabapentin use, according to research published online Sept. 9 in Pain Practice.
(HealthDay)—A robotic-assisted platform is safe and feasible for peripheral vascular intervention in patients with peripheral artery disease (PAD), according to a study published online Sept. 14 in JACC: Cardiovascular ...